NCT06029309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,816 public trials
701 recruiting studies
Lymphoma, Non-Hodgkin trial results
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
NCT05296070
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Miami Miami, Florida, United States
- Emory University Atlanta, Georgia, United States
- Vanderbilt University Nashvile, Tennessee, United States
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Anchorage, Alaska, United States
- Research Site Phoenix, Arizona, United States
- Research Site Clovis, California, United States
NCT05615636
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04752826
- Conditions
- Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- Rigshospitalet Copenhagen, Denmark
NCT07422610
- Conditions
- Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Novartis Investigative Site Bordeaux, France
- Novartis Investigative Site Saint-Herblain, France
- Novartis Investigative Site Candiolo, TO, Italy
- Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
Recruiting
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
NCT07223021
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- Cincinnati Children's Hospital Medical Center (Data Collection Only) Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia (Data Collection Only) Philadelphia, Pennsylvania, United States
- Baylor College Medical Center (Data Collection Only) Houston, Texas, United States
NCT07341191
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA - Vancouver Vancouver, British Columbia, Canada
- University Health Network Toronto, Ontario, Canada
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
NCT05757219
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States